Article Text

Download PDFPDF
Viral infections in paediatric patients receiving conventional cancer chemotherapy
  1. A Simon1,
  2. O Schildgen2,
  3. F Schuster2
  1. 1
    Children’s Hospital Medical Centre, University of Bonn, Bonn, Germany
  2. 2
    Pediatric Oncology, Hematology and Immunology, University Hospital of Düsseldorf, Düsseldorf, Germany
  3. 3
    Institute for Virology, University of Bonn, Bonn, Germany
  1. Dr Arne Simon, Pediatric Hematology and Oncology, Children’s Hospital Medical Centre, University of Bonn, Adenauerallee 119, 53113 Bonn, Germany; asimon{at}


In severely immunocompromised patients, the diagnosis of viral infections relies on PCR/RT-PCR based methods. The availability of these modern diagnostic tools facilitates timely diagnosis and contributes to our increasing knowledge of the epidemiology and clinical spectrum of common and emerging viral pathogens in this highly susceptible population. Viral infections may result in life threatening disease in paediatric cancer patients after stem cell transplantation and also during conventional chemotherapy. Often, clinical symptoms are a consequence of endogenous reactivation of latent viral infection. Many of these viruses are easily transmitted between patients, relatives and health care workers. As prolonged symptomatic and asymptomatic viral shedding is a common feature in paediatric cancer patients, it is necessary to implement strategies for the prevention and control of these communicable pathogens in the hospital setting and in the outpatient clinic. Although no randomised controlled studies on paediatric cancer patients are available, physicians should be aware of potential treatment options since early treatment may prevent a complicated or fatal outcome and shorten the period of contagiosity.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None.